A protective mutation against Alzheimer disease?

Communicative and Integrative Biology

Volumn 5, Issue 4, 2012, Pages 301-303

  Proft, Juliane ^a   Weiss, Norbert ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Secretase; Alzheimer disease; Amyloid beta (A ); Amyloid precursor protein (APP); BACE1

Indexed keywords

EID: 84869816965     PISSN: 19420889     EISSN: 19420889     Source Type: Journal    
DOI: 10.4161/cib.21799     Document Type: Article

References (24)

1. International WHOWaAsd. Dementia a public health priority. WHO, 2012.
2. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al.; Alzheimer's Disease International. Global prevalence of dementia: a Delphi consensus study. Lancet 2005; 366:2112-7; http://dx.doi.org/10.1016/S0140-6736(05)67889-0.
3. Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, et al. Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology 2007; 29:125-32; http://dx.doi.org/10.1159/000109998.
4. Qiu C, Kivipelto M, von Strauss E. Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci 2009; 11:111-28.
5. Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol 2011; 7:137-52; http://dx.doi.org/10.1038/nrneurol.2011.2.
6. Alzheimer A, Stelzmann RA, Schnitzlein HN, Murtagh FR. An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde". Clin Anat 1995; 8:429-31; http://dx.doi.org/10.1002/ca.980080612.
7. Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med 2010; 362:329-44; http://dx.doi.org/10.1056/NEJMra0909142.
8. Kandalepas PC, Vassar R. Identification and biology of β-secretase. J Neurochem 2012; 120(Suppl 1):55-61; http://dx.doi.org/10.1111/ j.1471-4159.2011.07512.x.
9. Esler WP, Wolfe MS. A portrait of Alzheimer secretases--new features and familiar faces. Science 2001; 293:1449-54; http://dx.doi. org/10.1126/science.1064638.
10. Hardy J, CaC, R. APP mutations table., 2010.
11. Cruts M, Theuns J, Van Broeckhoven C. Locusspecific mutation databases for neurodegenerative brain diseases. Hum Mutat 2012; http://dx.doi.org/10.1002/humu.22117.
12. Cruts M. Alzheimer's disease and frontotemporal dementia mutation database. 2012.
13. St George-Hyslop PH. Molecular genetics of Alzheimer's disease. Biol Psychiatry 2000; 47:183-99; http://dx.doi.org/10.1016/ S0006-3223(99)00301-7.
14. Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, et al. A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature 2012; 488:96-9; http://dx.doi.org/10.1038/nature11283.
15. Di Fede G, Catania M, Morbin M, Rossi G, Suardi S, Mazzoleni G, et al. A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis. Science 2009; 323:1473-7; http://dx.doi.org/10.1126/science.1168979.
16. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297:353-6; http://dx.doi.org/10.1126/science. 1072994.
17. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999; 286:735-41; http://dx.doi. org/10.1126/science.286.5440.735.
18. Sinha S, Anderson JP, Barbour R, Basi GS, Caccavello R, Davis D, et al. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 1999; 402:537-40; http:// dx.doi.org/10.1038/990114.
19. Yan R, Bienkowski MJ, Shuck ME, Miao H, Tory MC, Pauley AM, et al. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 1999; 402:533-7; http://dx.doi.org/10.1038/990107.
20. Willem M, Garratt AN, Novak B, Citron M, Kaufmann S, Rittger A, et al. Control of peripheral nerve myelination by the beta-secretase BACE1. Science 2006; 314:664-6; http:// dx.doi.org/10.1126/science.1132341.
21. Farah MH, Pan BH, Hoffman PN, Ferraris D, Tsukamoto T, Nguyen T, et al. Reduced BACE1 activity enhances clearance of myelin debris and regeneration of axons in the injured peripheral nervous system. J Neurosci 2011; 31:5744-54; http://dx.doi.org/10.1523/ JNEUROSCI.6810-10.2011.
22. Fleck D, Garratt AN, Haass C, Willem M. BACE1 dependent neuregulin processing: review. [review]. Curr Alzheimer Res 2012; 9:178-83; http://dx.doi. org/10.2174/156720512799361637.
23. Velanac V, Unterbarnscheidt T, Hinrichs W, Gummert MN, Fischer TM, Rossner MJ, et al. Bace1 processing of NRG1 type III produces a myelin-inducing signal but is not essential for the stimulation of myelination. Glia 2012; 60:203-17; http://dx.doi.org/10.1002/ glia.21255.
24. Grant JL, Ghosn EE, Axtell RC, Herges K, Kuipers HF, Woodling NS, et al. Reversal of Paralysis and Reduced Inf lammation from Peripheral Administration of beta-Amyloid in TH1 and TH17 Versions of Experimental Autoimmune Encephalomyelitis. Sci Transl Med 2012, 4:145ra05.